SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039927
Filing Date
2023-08-08
Accepted
2023-08-08 16:53:06
Documents
54
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tern-20230630.htm   iXBRL 10-Q 2570111
2 EX-31.1 tern-ex31_1.htm EX-31.1 21292
3 EX-31.2 tern-ex31_2.htm EX-31.2 21286
4 EX-32.1 tern-ex32_1.htm EX-32.1 12059
5 EX-32.2 tern-ex32_2.htm EX-32.2 12053
  Complete submission text file 0000950170-23-039927.txt   10079020

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tern-20230630_pre.xml EX-101.PRE 398238
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tern-20230630_def.xml EX-101.DEF 245642
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tern-20230630_cal.xml EX-101.CAL 45943
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tern-20230630_lab.xml EX-101.LAB 535502
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tern-20230630.xsd EX-101.SCH 65224
48 EXTRACTED XBRL INSTANCE DOCUMENT tern-20230630_htm.xml XML 2200053
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39926 | Film No.: 231152242
SIC: 2834 Pharmaceutical Preparations